Stem Cell Therapy Global Market Report 2022: Allogeneic Stem Cell Therapy; Autologous Stem Cell Therapy - ResearchAndMarkets.com

The "Stem Cell Therapy Global Market Report 2022: By Type, By Cell, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering.

The global stem cell therapy market is expected to grow from $10.67 billion in 2021 to $11.99 billion in 2022 at a compound annual growth rate (CAGR) of 12.4%. The market is expected to reach $21.17 billion in 2026 at a CAGR of 15.3%.

The stem cell therapy market consists of the sales of stem cell therapy and related services by entities (organizations, sole traders, and partnerships) that provide stem cell therapy. Stem cell therapy, also known as regenerative medicine, promotes the repair response of diseased patient, dysfunctional or injured tissue using stem cells or their derivatives. Only goods and services traded between entities or sold to end consumers are included.

The main types of stem cell therapy are allogeneic stem cell therapy and autologous stem cell therapy. Allogeneic stem cell transplantation involves transferring stem cells from a healthy person (the donor) to the patient's body after high-intensity chemotherapy or radiation,. The various sources of cell include adult stem cells; induced pluripotent stem cells and embryonic stem cells that are used for the treatment of musculoskeletal disorders; wounds and injuries; cancer; autoimmune disorders and others. The therapies are used by hospitals and clinics.

North America was the largest region in the stem cell therapy market in 2021. Middle East is expected to be the largest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The rising prevalence of chronic diseases contributed to the growth of the stem cell therapy market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases among people, thus driving the need for stem cell therapy. According to a United Nations article, by 2030, the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic diseases is expected to reach about 60%. The rising prevalence of chronic diseases is expected to drive the stem cell therapy market.

The high cost of stem cell therapy is expected to limit the growth of the stem cell therapy market. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding.

In less wealthy countries, the lack of cost-effective therapies for chronic diseases has impacted the health conditions of the population and has led to a low average life expectancy. According to the DVCSTEM, the average cost of stem cell therapy in the USA is between $20,000 to $25,000, in Mexico, it is $33,000, in Central America, it is $30,000, and in Asia, it is $50,000, thus restraining the growth of the market.

The companies in the stem cell therapy market are increasingly investing in strategic partnerships. The strategic partnership is a mutually beneficial agreement between two companies that do not compete directly with each other.

Major players in the stem cell therapy market are

• Anterogen
• JCR Pharmaceuticals
• Medipost
• Osiris Therapeutics
• Pharmicell
• Astellas Pharma
• Cellectis
• Celyad
• Novadip Biosciences
• Gamida Cell
• Capricor Therapeutics
• Cellular Dynamics
• CESCA Therapeutics
• DiscGenics
• OxStem
• Mesoblast
• ReNeuron Group
• Takeda Pharmaceuticals
• Magellan
• Kolon TissueGene
• Stemedica Cell Technologies
• Holostem Terapie Avanzate S.r.l.
• NuVasive
• RTI Surgical
• AlloSource

Key Topics Covered:

1. Executive Summary

2. Stem Cell Therapy Market Characteristics

3. Stem Cell Therapy Market Trends And Strategies

4. Impact Of COVID-19 On Stem Cell Therapy

5. Stem Cell Therapy Market Size And Growth

5.1. Global Stem Cell Therapy Historic Market, 2016-2021, $ Billion

5.1.1. Drivers Of The Market

5.1.2. Restraints On The Market

5.2. Global Stem Cell Therapy Forecast Market, 2021-2026F, 2031F, $ Billion

5.2.1. Drivers Of The Market

5.2.2. Restraints On the Market

6. Stem Cell Therapy Market Segmentation

6.1. Global Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy

6.2. Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Adult Stem Cells
• Induced Pluripotent Stem Cells
• Embryonic Stem Cells

6.3. Global Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Musculoskeletal Disorders
• Wounds and Injuries
• Cancer
• Autoimmune Disorders
• Others

6.4. Global Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Hospitals

7. Stem Cell Therapy Market Regional And Country Analysis

7.1. Global Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7.2. Global Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/15018b

View source version on businesswire.com: https://www.businesswire.com/news/home/20220617005241/en/